학술논문

First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes
Document Type
Article
Source
In: BMC Medicine. (BMC Medicine, December 2023, 21(1))
Subject
Language
English
ISSN
17417015